The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partner Company Update

28 Mar 2012 07:00

RNS Number : 2148A
Amphion Innovations PLC
28 March 2012
 



 

 

Amphion Partner Company Secures Credit Agreement

 

London and New York 28 March 2012 - Amphion Innovations plc (LSE: AMP) announces that its Partner Company, Axcess International Inc. (AXSI.PK), a provider of intelligent Wireless IDs, has entered into a credit agreement with RFID LLC. The immediate credit facility totals $1.48 million and under circumstances related primarily to the intellectual property litigation activities, a total of $10 million could be made available.

Axcess has a portfolio of patents, of which 11 have issued to date and 2 are still in prosecution with the United States Patent and Trademark Office (USPTO). Axcess filed a lawsuit in Dallas in the 132nd District Court for the State of Texas, Case 3:10-cv-01033-F on Friday 21 May 2010 against Savi Technology, Inc., a wholly-owned subsidiary of Lockheed Martin Corporation, alleging infringement of U.S. Patent Nos. 6,294,953 entitled "High Sensitivity Demodulator For A Radio Tag And Method", and 7,271,727 entitled "Dual Frequency Radio Tag For A Radio Frequency Identification System". The trial is set for the first quarter of 2013 and various pre-trial motions and hearings are under way, including preparations for a Markman hearing which is now scheduled for 9 April 2012

The credit agreement provides for the funding of a patent licensing programme to begin in 2012 designed to provide additional revenue to the company based on the 11 patents in its portfolio. The agreement further provides the potential to restructure short term debt, pay accrued legal bills related to the various patent litigation activities, and to provide funding for overhead and administrative operations. The returns to the investors participating in the credit agreement will, in most circumstances, accrue mainly from the patent litigation and patent licensing programmes.

Allan Griebenow, President and CEO of Axcess said, "Axcess International's intellectual property is the cornerstone to a broad range of automated wireless identification applications in use today. We see the harvesting of our IP portfolio with the help of partners such as RFID LLC as a key element of Axcess' business going forward. This credit facility is an important step in the prosecution of our current infringement actions with Savi, which we believe will create potential licensing opportunities and a financial platform in support of our continuing operations."

 

Richard Morgan, CEO of Amphion and Chairman of Axcess, added, "Good intellectual property is one of the critical foundations of each of our Partner Companies. We have worked closely with Axcess over many years to develop innovative products based on defensible patents and other intellectual property. We are pleased that this investor group shares our belief, supported by our first class legal teams, that Axcess' technology and IP is an important part of this broad and growing industry. We are committed to extracting fair value for our inventions through success in the market with innovative products and leading partners as well as from licenses from those who seek to practice the art covered by our patents".

 

Following additional investment in support of Axcess over the last few years, Amphion Innovations' ownership of Axcess is now 13.8% through its holdings of equity and warrants. Amphion's ownership excludes approximately $1.8 million in debt most of which is convertible into common stock.

 

For further information please contact:

Amphion Innovations plc

Charlie Morgan +1 212 210 6224

 

Cardew Group

Tim Robertson +44 20 7930 0777

 

Seymour Pierce Limited (Nominated Adviser)

Freddie Crossley/ Mark Percy +44 20 7107 8300

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has a significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

 

On the web: www.amphionplc.com

 

About Axcess International Inc.

Axcess International Inc. (OTCBB: AXSI) provides intelligent Wireless IDs for business encompassing local location identification, tracking and control capabilities using its patented MicroWirelessTM technology platform. MicroWireless, which is based on active RFID principles, forms the economic and technological sweet spot for automated, autonomously-powered low cost, miniature, wireless devices. Axcess is a Partner Company of Amphion Innovations plc (AIM: AMP). For more information on Axcess, visit www.axcessinc.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBUBRUOAOUAR
Date   Source Headline
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.